Kyle J Moody
Examiner (ID: 8172, Phone: (571)272-5242 , Office: P/2838 )
Most Active Art Unit | 2838 |
Art Unit(s) | 2838 |
Total Applications | 778 |
Issued Applications | 667 |
Pending Applications | 60 |
Abandoned Applications | 51 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17881201
[patent_doc_number] => 20220296678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => LIQUID FORMULATIONS COMPRISING MUTANT FGF-21 PEPTIDE PEGYLATED CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 17/692024
[patent_app_country] => US
[patent_app_date] => 2022-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23844
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17692024
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/692024 | Liquid formulations comprising mutant FGF-21 peptide pegylated conjugates | Mar 9, 2022 | Issued |
Array
(
[id] => 17837753
[patent_doc_number] => 20220275058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => PURIFICATION OF FACTOR VIII SUBSPECIES
[patent_app_type] => utility
[patent_app_number] => 17/688588
[patent_app_country] => US
[patent_app_date] => 2022-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45545
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17688588
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/688588 | Purification of Factor VIII subspecies | Mar 6, 2022 | Issued |
Array
(
[id] => 17828529
[patent_doc_number] => 20220265833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => ASPARTIC PROTEASE-TRIGGERED ANTIFUNGAL HYDROGELS
[patent_app_type] => utility
[patent_app_number] => 17/682782
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11863
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17682782
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/682782 | ASPARTIC PROTEASE-TRIGGERED ANTIFUNGAL HYDROGELS | Feb 27, 2022 | Pending |
Array
(
[id] => 17789645
[patent_doc_number] => 20220248736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => DIETARY PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/678574
[patent_app_country] => US
[patent_app_date] => 2022-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17678574
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/678574 | DIETARY PEPTIDES | Feb 22, 2022 | Pending |
Array
(
[id] => 18013311
[patent_doc_number] => 11505593
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Anti-VEGF protein compositions and methods for producing the same
[patent_app_type] => utility
[patent_app_number] => 17/667298
[patent_app_country] => US
[patent_app_date] => 2022-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 86
[patent_no_of_words] => 68043
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17667298
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/667298 | Anti-VEGF protein compositions and methods for producing the same | Feb 7, 2022 | Issued |
Array
(
[id] => 18398256
[patent_doc_number] => 11660372
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-30
[patent_title] => Silk-hyaluronic acid based tissue fillers and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 17/592312
[patent_app_country] => US
[patent_app_date] => 2022-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 93184
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17592312
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/592312 | Silk-hyaluronic acid based tissue fillers and methods of using the same | Feb 2, 2022 | Issued |
Array
(
[id] => 18020579
[patent_doc_number] => 20220372078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => POLYPETIDE, PHOTORESIST COMPOSITION INCLUDING THE SAME, AND METHOD OF FORMING PATTERN USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/578720
[patent_app_country] => US
[patent_app_date] => 2022-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17578720
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/578720 | Polypetide, photoresist composition including the same, and method of forming pattern using the same | Jan 18, 2022 | Issued |
Array
(
[id] => 17749631
[patent_doc_number] => 20220227835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/575425
[patent_app_country] => US
[patent_app_date] => 2022-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67559
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17575425
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/575425 | Anti-VEGF protein compositions and methods for producing the same | Jan 12, 2022 | Issued |
Array
(
[id] => 17837716
[patent_doc_number] => 20220275021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => SOLID PHASE PEPTIDE SYNTHESIS PROCESSES AND ASSOCIATED SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 17/558525
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24984
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17558525
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/558525 | SOLID PHASE PEPTIDE SYNTHESIS PROCESSES AND ASSOCIATED SYSTEMS | Dec 20, 2021 | Abandoned |
Array
(
[id] => 17640724
[patent_doc_number] => 20220168462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => VASCULAR EMBOLIC SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/535470
[patent_app_country] => US
[patent_app_date] => 2021-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10771
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17535470
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/535470 | VASCULAR EMBOLIC SYSTEM | Nov 23, 2021 | Pending |
Array
(
[id] => 19256867
[patent_doc_number] => 12016896
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Dipeptidomimetics as inhibitors of human immunoproteasomes
[patent_app_type] => utility
[patent_app_number] => 17/532285
[patent_app_country] => US
[patent_app_date] => 2021-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19236
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17532285
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/532285 | Dipeptidomimetics as inhibitors of human immunoproteasomes | Nov 21, 2021 | Issued |
Array
(
[id] => 17805870
[patent_doc_number] => 20220257705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => ACE INHIBITORY PEPTIDE COMPOSITION DERIVED FROM GINKGO PROTEIN AND PREPARATION METHOD AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/455684
[patent_app_country] => US
[patent_app_date] => 2021-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7579
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17455684
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/455684 | ACE INHIBITORY PEPTIDE COMPOSITION DERIVED FROM GINKGO PROTEIN AND PREPARATION METHOD AND APPLICATION THEREOF | Nov 18, 2021 | Abandoned |
Array
(
[id] => 19353017
[patent_doc_number] => 12053442
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-06
[patent_title] => Methods and compositions for neuroprotection
[patent_app_type] => utility
[patent_app_number] => 17/527987
[patent_app_country] => US
[patent_app_date] => 2021-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 28
[patent_no_of_words] => 18535
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17527987
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/527987 | Methods and compositions for neuroprotection | Nov 15, 2021 | Issued |
Array
(
[id] => 17428390
[patent_doc_number] => 20220056098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => ULTRA-LONG ACTING INSULIN-FC FUSION PROTEIN AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/527486
[patent_app_country] => US
[patent_app_date] => 2021-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22930
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17527486
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/527486 | Ultra-long acting insulin-Fc fusion protein and methods of use | Nov 15, 2021 | Issued |
Array
(
[id] => 17843773
[patent_doc_number] => 11433115
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-06
[patent_title] => Glycopeptide antibiotics liquid formulations and methods and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/512321
[patent_app_country] => US
[patent_app_date] => 2021-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13348
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17512321
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/512321 | Glycopeptide antibiotics liquid formulations and methods and uses thereof | Oct 26, 2021 | Issued |
Array
(
[id] => 17775022
[patent_doc_number] => 20220241371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => PEPTIDE FORMULATIONS AND OPHTHALMIC USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/508388
[patent_app_country] => US
[patent_app_date] => 2021-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17508388
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/508388 | PEPTIDE FORMULATIONS AND OPHTHALMIC USES THEREOF | Oct 21, 2021 | Pending |
Array
(
[id] => 17398166
[patent_doc_number] => 20220040256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => ARTHROFACTIN FOR THE TREATMENT OF ACNE
[patent_app_type] => utility
[patent_app_number] => 17/506994
[patent_app_country] => US
[patent_app_date] => 2021-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6386
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17506994
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/506994 | Arthrofactin for the treatment of acne | Oct 20, 2021 | Issued |
Array
(
[id] => 18075060
[patent_doc_number] => 20220400672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => IDL7 MATURE POLYPEPTIDE PLANT SENESCENCE ACCELERATOR, PREPARATION METHOD AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/501988
[patent_app_country] => US
[patent_app_date] => 2021-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17501988
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/501988 | IDL7 MATURE POLYPEPTIDE PLANT SENESCENCE ACCELERATOR, PREPARATION METHOD AND APPLICATION THEREOF | Oct 13, 2021 | Abandoned |
Array
(
[id] => 17503501
[patent_doc_number] => 20220096603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => INSULIN FORMULATIONS AND USES IN INFUSION DEVICES
[patent_app_type] => utility
[patent_app_number] => 17/487601
[patent_app_country] => US
[patent_app_date] => 2021-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9357
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17487601
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/487601 | INSULIN FORMULATIONS AND USES IN INFUSION DEVICES | Sep 27, 2021 | Pending |
Array
(
[id] => 17828454
[patent_doc_number] => 20220265758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS
[patent_app_type] => utility
[patent_app_number] => 17/482699
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17714
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17482699
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/482699 | Peptide epoxyketone proteasome inhibitors in combination with PIM kinase inhibitors for treatment of cancers | Sep 22, 2021 | Issued |